August 13, 2023
Alpha 9 Theranostics is a clinical-stage biopharmaceutical company founded in 2019 by renowned scientists based at BC Cancer and the University of British Columbia.
The Company is using its world-class know-how in molecular design and targeting of radiotherapeutics to advance a portfolio of breakthrough technologies focused on the precision targeting of metastatic cancer. These technologies promise to potentially revolutionize the way in which metastatic cancer is both diagnosed and treated.
August 13, 2023